{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:12:34Z","timestamp":1759104754920},"reference-count":9,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            For broth microdilution susceptibility tests of\n            <jats:italic>Francisella tularensis<\/jats:italic>\n            , Mueller-Hinton broth with 2% Isovitalex is recommended. Using that medium, we studied three standard control strains tested with nine antimicrobial agents potentially efficacious for treating tularemia. An eight-laboratory collaborative study generated the data needed to propose appropriate MIC control limits.\n          <\/jats:p>","DOI":"10.1128\/jcm.42.12.5877-5880.2004","type":"journal-article","created":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T23:38:07Z","timestamp":1102376287000},"page":"5877-5880","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Broth Microdilution Susceptibility Testing of\n            <i>Francisella tularensis<\/i>\n            : Quality Control Limits for Nine Antimicrobial Agents and Three Standard Quality Control Strains"],"prefix":"10.1128","volume":"42","author":[{"given":"Steven D.","family":"Brown","sequence":"first","affiliation":[{"name":"Clinical Microbiology Institute, Wilsonville, Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Krisher","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Institute, Wilsonville, Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria M.","family":"Traczewski","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Institute, Wilsonville, Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.22.2.212-215.1985"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(89)90112-0"},{"key":"e_1_3_2_4_2","first-page":"182","volume":"51","year":"2002","unstructured":"Centers for Disease Control and Prevention. 2002. Tularemia\u2014United States, 1990-2000. Morb. Mortal. Wkly. Rep.51:182-184.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_5_2","first-page":"452","volume":"287","year":"2001","unstructured":"Dennis, D. T., T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, M. Layton, S. R. Lillibridge, J. E. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, K. Tonat, and the Working Group on Civilian Biodefense. 2001. Tularemia as a biological weapon: medical and public health management. JAMA287:452-453.","journal-title":"JAMA"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.4.631-646.2002"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.2.287"},{"key":"e_1_3_2_8_2","unstructured":"National Committee for Clinical Laboratory Standards. 2003. Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. National Committee for Clinical Lab-oratory Standards Wayne Pa."},{"key":"e_1_3_2_9_2","unstructured":"National Committee for Clinical Laboratory Standards. 2001. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline M23-A2. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.1.174"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.42.12.5877-5880.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.42.12.5877-5880.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:46:00Z","timestamp":1646448360000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.42.12.5877-5880.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1128\/JCM.42.12.5877-5880.2004"],"URL":"https:\/\/doi.org\/10.1128\/jcm.42.12.5877-5880.2004","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"2004-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-08-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}